PRMT5 and cancer: We have recently shown that PRMT5 functions as a master epigenetic activator of DDR genes, and that targeting PRMT5 by genetic knockdown or pharmacological inhibition can sensitize multiple cancer cell lines to radiation and chemotherapy [17].